+44 (0) 20 7549 9987 | USA callers: +1 212 220 8419

Contact Us Now

The Pre-Filled Syringes Market Will Reach $6,940m In 2020 Predicts New Visiongain Report

10 September 2018
Pharma

A new report by visiongain predicts that the Pre-Filled Syringes market will reach $6,940m in 2020. This forecast and others appear in Pre-Filled Syringes Market Forecast 2016-2026: Prospects for Leading Companies in Plastic Pre-Filled Syringes, Pen Injector & Autoinjectors, and Glass Pre-Filled Syringes published in April 2016. Visiongain is a business information provider based in London, UK.

The Pre-Filled Syringes Market Forecast 2016-2026 report examines the current and future trends in the growing pre-filled syringes market. Glass syringes have long dominated the market, however the improved characteristics of plastic syringes, an increasing adoption of autoinjectors and pen injectors, as well as the advent of needle-free delivery systems are posing a threat to the continued dominance of glass syringes. The large number of injectable drugs in the pipeline and increasing number of approved biosimilars is helping to spur demand for pre-filled syringes, despite newer oral therapies being much preferred by patients.

In this report, we examine in detail some of the main national markets in the market, analyse and forecast the major treatment areas that use pre-filled syringes, as well as forecast specific products that are delivered in pre-filled syringes. In addition, the report includes an in-depth discussion of the main companies in the market, including historical revenues and product details when available. Qualitative analysis of the market is given, taking into account governmental policy and regulation, safety, features and more.

Visiongain’s report provides revenue forecasts to 2026 for the Pre-Filled Syringes market, its leading national markets, therapeutics areas and products. The report discusses selected leading companies in the market. These companies include Becton, Dickinson and Company, Gerresheimer, Schott, Baxter, Nipro, Weigao, Unilife, Roselabs, SHL Group, Ypsomed, Haselmeier, Owen Mumford, Bespak and Datwyler.

Pre-Filled Syringes Market Forecast 2016-2026: Prospects for Leading Companies in Plastic Pre-Filled Syringes, Pen Injector & Autoinjectors, and Glass Pre-Filled Syringes adds to visiongain’s range of analytical reports on industries and markets in healthcare.
For an executive summary please contact:
Email: Sara Peerun on sara.peerun@visiongainglobal.com
Tel: +44 (0) 20 7336 6100

Notes for Editors

If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain

Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. From its head office in London, UK, visiongain produces a range of newsletters, business reports and e-zines covering current affairs and market trends in the Energy, Telecoms, Pharmaceutical, Defence, and Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high quality, original analyses to inform their strategic decisions.

Recent News

Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034

The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.

23 April 2024

Read

Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

18 April 2024

Read

Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

17 April 2024

Read

Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

12 April 2024

Read